{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T01:09:47Z","timestamp":1791421787979,"version":"4.3.3"},"reference-count":68,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2012,9,1]],"date-time":"2012-09-01T00:00:00Z","timestamp":1346457600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,9,1]],"date-time":"2012-09-01T00:00:00Z","timestamp":1346457600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["celltherapyjournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytotherapy"],"published-print":{"date-parts":[[2012,9]]},"DOI":"10.3109\/14653249.2012.700766","type":"journal-article","created":{"date-parts":[[2012,7,17]],"date-time":"2012-07-17T09:06:52Z","timestamp":1342516012000},"page":"1110-1118","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":88,"title":["Human Vdelta1 gamma-delta T cells exert potent specific cytotoxicity against primary multiple myeloma cells"],"prefix":"10.1016","volume":"14","author":[{"given":"Andrea","family":"Knight","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Mackinnon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark W.","family":"Lowdell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.3109\/14653249.2012.700766_bib0005","doi-asserted-by":"crossref","first-page":"2272","DOI":"10.1073\/pnas.93.6.2272","article-title":"Gamma\/delta and other unconventional T lymphocytes: what do they see and what do they do?","volume":"93","author":"Kaufmann","year":"1996","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.3109\/14653249.2012.700766_bib0010","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1146\/annurev.immunol.18.1.975","article-title":"[gamma][delta] cells: a right time and a right place for a conserved third way of protection","volume":"18","author":"Hayday","year":"2000","journal-title":"Annu Rev Immunol"},{"key":"10.3109\/14653249.2012.700766_bib0015","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1038\/nri797","article-title":"Gammadelta T cells: functional plasticity and heterogeneity","volume":"2","author":"Carding","year":"2002","journal-title":"Nat Rev Immunol"},{"key":"10.3109\/14653249.2012.700766_bib0020","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.coi.2005.01.009","article-title":"Gammadelta T cell development: having the strength to get there","volume":"17","author":"Pennington","year":"2005","journal-title":"Curr Opin Immunol"},{"key":"10.3109\/14653249.2012.700766_bib0025","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1158\/0008-5472.CAN-06-3069","article-title":"Perspectives of gammadelta T cells in tumor immunology","volume":"67","author":"Kabelitz","year":"2007","journal-title":"Cancer Res"},{"key":"10.3109\/14653249.2012.700766_bib0030","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1111\/j.1365-3083.2007.01963.x","article-title":"Lysis of a broad range of epithelial tumour cells by human gamma delta T cells: involvement of NKG2D ligands and T-cell receptor- versus NKG2D-dependent recognition","volume":"66","author":"Wrobel","year":"2007","journal-title":"Scand J Immunol"},{"key":"10.3109\/14653249.2012.700766_bib0035","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.imlet.2007.03.002","article-title":"Human gammadelta T lymphocytes strip and kill tumor cells simultaneously","volume":"110","author":"Gertner","year":"2007","journal-title":"Immunol Lett"},{"key":"10.3109\/14653249.2012.700766_bib0040","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1126\/science.285.5428.727","article-title":"Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA","volume":"285","author":"Bauer","year":"1999","journal-title":"Science"},{"key":"10.3109\/14653249.2012.700766_bib0045","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1034\/j.1399-0039.2003.00070.x","article-title":"NKG2D ligands: unconventional MHC class I-like molecules exploited by viruses and cancer","volume":"61","author":"Cerwenka","year":"2003","journal-title":"Tissue Antigens"},{"key":"10.3109\/14653249.2012.700766_bib0050","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S1074-7613(01)00095-4","article-title":"ULBPs, novel MHC class I-related molecules, bind to CMV glycoprotein UL16 and stimulate NK cytotoxicity through the NKG2D receptor","volume":"14","author":"Cosman","year":"2001","journal-title":"Immunity"},{"key":"10.3109\/14653249.2012.700766_bib0055","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.immuni.2004.11.012","article-title":"Tumor recognition following Vgamma9Vdelta2 T cell receptor interactions with a surface F1-ATPase-related structure and apolipoprotein A-I","volume":"22","author":"Scotet","year":"2005","journal-title":"Immunity"},{"key":"10.3109\/14653249.2012.700766_bib0060","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/j.bbrc.2007.01.031","article-title":"Gamma delta T cells kill myeloma cells by sensing mevalonate metabolites and ICAM-1 molecules on cell surface","volume":"354","author":"Uchida","year":"2007","journal-title":"Biochem Biophys Res Commun"},{"key":"10.3109\/14653249.2012.700766_bib0065","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1002\/eji.200838409","article-title":"DNAX accessory molecule-1 (CD226) promotes human hepatocellular carcinoma cell lysis by Vgamma9Vdelta2 T cells","volume":"39","author":"Toutirais","year":"2009","journal-title":"Eur J Immunol"},{"key":"10.3109\/14653249.2012.700766_bib0070","doi-asserted-by":"crossref","unstructured":"Lanca T, Correia DV, Moita CF, Raquel H, Neves-Costa A, Ferreira C, et al. The MHC class Ib protein ULBP1 is a nonredundant determinant of leukemia\/lymphoma susceptibility to gammadelta T-cell cytotoxicity. Blood.2010;115:2407\u201311.","DOI":"10.1182\/blood-2009-08-237123"},{"key":"10.3109\/14653249.2012.700766_bib0075","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1182\/blood-2008-12-196287","article-title":"The NKG2D ligand ULBP4 binds to TCRgamma9\/delta2 and induces cytotoxicity to tumor cells through both TCRgammadelta and NKG2D","volume":"114","author":"Kong","year":"2009","journal-title":"Blood"},{"key":"10.3109\/14653249.2012.700766_bib0080","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1182\/blood-2011-02-339135","article-title":"Differentiation of human peripheral blood V{delta}1 + T cells expressing the natural cytotoxicity receptor NKp30 for recognition of lymphoid leukemia cells","volume":"118","author":"Correia","year":"2011","journal-title":"Blood"},{"key":"10.3109\/14653249.2012.700766_bib0085","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1111\/j.1365-2249.2006.03078.x","article-title":"Activated gammadelta T cells express the natural cytotoxicity receptor natural killer p44 and show cytotoxic activity against myeloma cells","volume":"144","author":"von Lilienfeld-Toal","year":"2006","journal-title":"Clin Exp Immunol"},{"key":"10.3109\/14653249.2012.700766_bib0090","first-page":"151","article-title":"Gammadelta T cells link innate and adaptive immune responses","volume":"86","author":"Kabelitz","year":"2005","journal-title":"Chem Immunol Allergy"},{"key":"10.3109\/14653249.2012.700766_bib0095","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/j.1600-065X.2006.00478.x","article-title":"Development and selection of gammadelta T cells","volume":"215","author":"Xiong","year":"2007","journal-title":"Immunol Rev"},{"key":"10.3109\/14653249.2012.700766_bib0100","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1111\/j.1365-2567.2004.01921.x","article-title":"Integrated immune responses to infection: cross-talk between human gammadelta T cells and dendritic cells","volume":"112","author":"Eberl","year":"2004","journal-title":"Immunology"},{"key":"10.3109\/14653249.2012.700766_bib0105","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1182\/blood.V98.5.1616","article-title":"Vgamma2Vdelta2 T-cell receptor-mediated recognition of aminobisphosphonates","volume":"98","author":"Das","year":"2001","journal-title":"Blood"},{"key":"10.3109\/14653249.2012.700766_bib0110","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.bone.2010.07.016","article-title":"Bisphosphonates\u2019 antitumor activity: an unravelled side of a multifaceted drug class","volume":"48","author":"Clezardin","year":"2011","journal-title":"Bone"},{"key":"10.3109\/14653249.2012.700766_bib0115","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1182\/blood.V96.2.384.013k07_384_392","article-title":"Stimulation of gammadelta T cells by aminobisphosphonates and induction of antiplasma cell activity in multiple myeloma","volume":"96","author":"Kunzmann","year":"2000","journal-title":"Blood"},{"key":"10.3109\/14653249.2012.700766_bib0120","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1182\/blood-2002-12-3665","article-title":"Gammadelta T cells for immune therapy of patients with lymphoid malignancies","volume":"102","author":"Wilhelm","year":"2003","journal-title":"Blood"},{"key":"10.3109\/14653249.2012.700766_bib0125","doi-asserted-by":"crossref","first-page":"5481","DOI":"10.4049\/jimmunol.175.8.5481","article-title":"V gamma 9V delta 2 T cell response to colon carcinoma cells","volume":"175","author":"Corvaisier","year":"2005","journal-title":"J Immunol"},{"key":"10.3109\/14653249.2012.700766_bib0130","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1007\/s00262-007-0391-3","article-title":"Vgamma9Vdelta2 T cell-mediated recognition of human solid tumors. Potential for immunotherapy of hepatocellular and colorectal carcinomas","volume":"57","author":"Bouet-Toussaint","year":"2008","journal-title":"Cancer Immunol Immunother"},{"key":"10.3109\/14653249.2012.700766_bib0135","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1016\/j.exphem.2009.04.008","article-title":"Clinical and immunological evaluation of zoledronate-activated Vgamma9gammadelta T-cell-based immunotherapy for patients with multiple myeloma","volume":"37","author":"Abe","year":"2009","journal-title":"Exp Hematol"},{"key":"10.3109\/14653249.2012.700766_bib0140","doi-asserted-by":"crossref","first-page":"3260","DOI":"10.4049\/jimmunol.0903454","article-title":"V gamma 9V delta 2 T lymphocytes efficiently recognize and kill zoledronate-sensitized, imatinib-sensitive, and imatinib-resistant chronic myelogenous leukemia cells","volume":"184","author":"D\u2019Asaro","year":"2010","journal-title":"J Immunol"},{"key":"10.3109\/14653249.2012.700766_bib0145","doi-asserted-by":"crossref","first-page":"7450","DOI":"10.1158\/0008-5472.CAN-07-0199","article-title":"Targeting human {gamma}delta} T cells with zoledronate and interleukin-2 for immunotherapy of hormone-refractory prostate cancer","volume":"67","author":"Dieli","year":"2007","journal-title":"Cancer Res"},{"key":"10.3109\/14653249.2012.700766_bib0150","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1111\/j.1365-2249.2010.04167.x","article-title":"In vivo manipulation of Vgamma9Vdelta2 T cells with zoledronate and low-dose interleukin-2 for immunotherapy of advanced breast cancer patients","volume":"161","author":"Meraviglia","year":"2010","journal-title":"Clin Exp Immunol"},{"key":"10.3109\/14653249.2012.700766_bib0155","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/s10549-009-0527-6","article-title":"Adoptively transferred ex vivo expanded gammadelta- T cells mediate in vivo antitumor activity in preclinical mouse models of breast cancer","volume":"122","author":"Beck","year":"2010","journal-title":"Breast Cancer Res Treat"},{"key":"10.3109\/14653249.2012.700766_bib0160","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/s11060-010-0245-2","article-title":"Preclinical evaluation of ex vivo expanded\/activated gammadelta T cells for immunotherapy of glioblastoma multiforme","volume":"101","author":"Bryant","year":"2011","journal-title":"J Neurooncol"},{"key":"10.3109\/14653249.2012.700766_bib0165","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1007\/s00262-006-0199-6","article-title":"Safety profile and anti-tumor effects of adoptive immunotherapy using gamma-delta T cells against advanced renal cell carcinoma: a pilot study","volume":"56","author":"Kobayashi","year":"2007","journal-title":"Cancer Immunol Immunother"},{"key":"10.3109\/14653249.2012.700766_bib0170","doi-asserted-by":"crossref","first-page":"7287","DOI":"10.4049\/jimmunol.0804288","article-title":"Efficient killing of human colon cancer stem cells by gammadelta T lymphocytes","volume":"182","author":"Todaro","year":"2009","journal-title":"J Immunol"},{"key":"10.3109\/14653249.2012.700766_bib0175","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1084\/jem.183.4.1681","article-title":"Human intestinal Vdelta1 + lymphocytes recognize tumor cells of epithelial origin","volume":"183","author":"Maeurer","year":"1996","journal-title":"J Exp Med"},{"key":"10.3109\/14653249.2012.700766_bib0180","doi-asserted-by":"crossref","first-page":"3932","DOI":"10.4049\/jimmunol.154.8.3932","article-title":"Selective lysis of autologous tumor cells by recurrent gamma delta tumor-infiltrating lymphocytes from renal carcinoma","volume":"154","author":"Choudhary","year":"1995","journal-title":"J Immunol"},{"key":"10.3109\/14653249.2012.700766_bib0185","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1084\/jem.20041851","article-title":"Shared reactivity of V{delta}2(neg) {gamma}{delta} T cells against cytomegalovirus-infected cells and tumor intestinal epithelial cells","volume":"201","author":"Halary","year":"2005","journal-title":"J Exp Med"},{"key":"10.3109\/14653249.2012.700766_bib0190","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1172\/JCI5409","article-title":"Implication of gammadelta T cells in the human immune response to cytomegalovirus","volume":"103","author":"Dechanet","year":"1999","journal-title":"J Clin Invest"},{"key":"10.3109\/14653249.2012.700766_bib0195","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1086\/322843","article-title":"Cytomegalovirus infection in transplant recipients resolves when circulating gammadelta T lymphocytes expand, suggesting a protective antiviral role","volume":"184","author":"Lafarge","year":"2001","journal-title":"J Infect Dis"},{"key":"10.3109\/14653249.2012.700766_bib0200","doi-asserted-by":"crossref","first-page":"2164","DOI":"10.1182\/blood-2010-01-255166","article-title":"The role of Vdelta2-negative gammadelta T cells during cytomegalovirus reactivation in recipients of allogeneic stem cell transplantation","volume":"116","author":"Knight","year":"2010","journal-title":"Blood"},{"key":"10.3109\/14653249.2012.700766_bib0205","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1038\/sj.bmt.1705650","article-title":"Long term disease-free survival in acute leukemia patients recovering with increased gammadelta T cells after partially mismatched related donor bone marrow transplantation","volume":"39","author":"Godder","year":"2007","journal-title":"Bone Marrow Transplant"},{"key":"10.3109\/14653249.2012.700766_bib0210","doi-asserted-by":"crossref","first-page":"9172","DOI":"10.1158\/0008-5472.CAN-04-2417","article-title":"Vdelta1 T lymphocytes from B-CLL patients recognize ULBP3 expressed on leukemic B cells and up-regulated by trans-retinoic acid","volume":"64","author":"Poggi","year":"2004","journal-title":"Cancer Res"},{"key":"10.3109\/14653249.2012.700766_bib0215","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1089\/scd.1.1996.5.503","article-title":"Increased frequency of TCR gamma delta + T cells in disease-free survivors following T cell-depleted, partially mismatched, related donor bone marrow transplantation for leukemia","volume":"5","author":"Lamb","year":"1996","journal-title":"J Hematother"},{"key":"10.3109\/14653249.2012.700766_bib0220","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1182\/blood-2006-06-028985","article-title":"Expansion of Vdelta1 T lymphocytes producing IL-4 in low-grade non-Hodgkin lymphomas expressing UL-16-binding proteins","volume":"109","author":"Catellani","year":"2007","journal-title":"Blood"},{"key":"10.3109\/14653249.2012.700766_bib0225","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.prp.2009.10.001","article-title":"Cancer immunoediting and \u2018spontaneous\u2019 tumor regression","volume":"206","author":"Sengupta","year":"2010","journal-title":"Pathol Res Pract"},{"key":"10.3109\/14653249.2012.700766_bib0230","doi-asserted-by":"crossref","first-page":"7502","DOI":"10.1158\/0008-5472.CAN-05-0731","article-title":"MICA expressed by multiple myeloma and monoclonal gammopathy of undetermined significance plasma cells costimulates pamidronate-activated gammadelta lymphocytes","volume":"65","author":"Girlanda","year":"2005","journal-title":"Cancer Res"},{"key":"10.3109\/14653249.2012.700766_bib0235","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1182\/blood-2006-09-044321","article-title":"Enhanced ability of dendritic cells to stimulate innate and adaptive immunity on short-term incubation with zoledronic acid","volume":"110","author":"Fiore","year":"2007","journal-title":"Blood"},{"key":"10.3109\/14653249.2012.700766_bib0240","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1002\/ijc.24758","article-title":"The bisphosphonate zoledronic acid has antimyeloma activity in vivo by inhibition of protein prenylation","volume":"126","author":"Guenther","year":"2010","journal-title":"Int J Cancer"},{"key":"10.3109\/14653249.2012.700766_bib0245","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1080\/10245330500094714","article-title":"Zoledronic acid exerts its antitumor effect in multiple myeloma interfering with the bone marrow microenvironment","volume":"10","author":"Corso","year":"2005","journal-title":"Hematology"},{"key":"10.3109\/14653249.2012.700766_bib0250","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.exphem.2010.10.005","article-title":"The proapoptotic effect of zoledronic acid is independent of either the bone microenvironment or the intrinsic resistance to bortezomib of myeloma cells and is enhanced by the combination with arsenic trioxide","volume":"39","author":"Abeltino","year":"2011","journal-title":"Exp Hematol"},{"key":"10.3109\/14653249.2012.700766_bib0255","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1080\/14653240802419328","article-title":"Zoledronate facilitates large-scale ex vivo expansion of functional gammadelta T cells from cancer patients for use in adoptive immunotherapy","volume":"10","author":"Kondo","year":"2008","journal-title":"Cytotherapy"},{"key":"10.3109\/14653249.2012.700766_bib0260","first-page":"86","article-title":"Molecular diversity of gammadelta T cells in peripheral blood from patients with B-cell chronic lymphocytic leukaemia","volume":"49","author":"Bartkowiak","year":"2002","journal-title":"Neoplasma"},{"key":"10.3109\/14653249.2012.700766_bib0265","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1111\/j.1365-3083.1993.tb01735.x","article-title":"A subset of V delta 1 + T cells proliferates in response to Epstein\u2013Barr virus-transformed B cell lines in vitro","volume":"38","author":"Orsini","year":"1993","journal-title":"Scand J Immunol"},{"key":"10.3109\/14653249.2012.700766_bib0270","doi-asserted-by":"crossref","first-page":"3199","DOI":"10.1002\/eji.1830241243","article-title":"Functional and molecular characterization of B cell-responsive V delta 1 + gamma delta T cells","volume":"24","author":"Orsini","year":"1994","journal-title":"Eur J Immunol"},{"key":"10.3109\/14653249.2012.700766_bib0275","doi-asserted-by":"crossref","first-page":"3984","DOI":"10.4049\/jimmunol.149.12.3984","article-title":"V delta 1 + subset of human gamma delta T cells responds to ligands expressed by EBV-infected Burkitt lymphoma cells and transformed B lymphocytes","volume":"149","author":"Hacker","year":"1992","journal-title":"J Immunol"},{"key":"10.3109\/14653249.2012.700766_bib0280","doi-asserted-by":"crossref","first-page":"2864","DOI":"10.1182\/blood-2010-09-309781","article-title":"Upregulation of cytolytic functions of human V{delta}2neg {gamma}{delta} T lymphocytes through engagement of ILT2 expressed by tumor target cells","volume":"117","author":"Harly","year":"2011","journal-title":"Blood"},{"key":"10.3109\/14653249.2012.700766_bib0285","doi-asserted-by":"crossref","first-page":"2419","DOI":"10.1007\/s00018-011-0704-8","article-title":"Vgamma9Vdelta2 T cell-based immunotherapy in hematological malignancies: from bench to bedside","volume":"68","author":"Castella","year":"2011","journal-title":"Cell Mol Life Sci"},{"key":"10.3109\/14653249.2012.700766_bib0290","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1007\/s00262-005-0094-6","article-title":"Characterization of the gammadelta T cell response to acute leukemia","volume":"55","author":"Meeh","year":"2006","journal-title":"Cancer Immunol Immunother"},{"key":"10.3109\/14653249.2012.700766_bib0295","doi-asserted-by":"crossref","first-page":"753","DOI":"10.3109\/14653249.2011.553595","article-title":"Human Vdelta1 gammadelta T cells expanded from peripheral blood exhibit specific cytotoxicity against B-cell chronic lymphocytic leukemia-derived cells","volume":"13","author":"Siegers","year":"2011","journal-title":"Cytotherapy"},{"key":"10.3109\/14653249.2012.700766_bib0300","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1038\/sj.bmt.1703043","article-title":"TCR gamma delta cytotoxic T lymphocytes expressing the killer cell-inhibitory receptor p58.2 (CD158b) selectively lyse acute myeloid leukemia cells","volume":"27","author":"Dolstra","year":"2001","journal-title":"Bone Marrow Transplant"},{"key":"10.3109\/14653249.2012.700766_bib0305","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1007\/BF03402114","article-title":"Different roles of the CD2 and LFA-1 T-cell co-receptors for regulating cytotoxic, proliferative, and cytokine responses of human V gamma 9\/V delta 2 T cells","volume":"6","author":"Wang","year":"2000","journal-title":"Mol Med"},{"key":"10.3109\/14653249.2012.700766_bib0310","doi-asserted-by":"crossref","first-page":"6578","DOI":"10.4049\/jimmunol.172.11.6578","article-title":"Mechanisms of Vdelta1 gammadelta T cell activation by microbial components","volume":"172","author":"Das","year":"2004","journal-title":"J Immunol"},{"key":"10.3109\/14653249.2012.700766_bib0315","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1084\/jem.173.2.297","article-title":"Selective activation of gamma\/delta + T cell clones by single anti-CD2 antibodies","volume":"173","author":"Wesselborg","year":"1991","journal-title":"J Exp Med"},{"key":"10.3109\/14653249.2012.700766_bib0320","doi-asserted-by":"crossref","first-page":"3827","DOI":"10.1182\/blood.V96.12.3827","volume":"96","author":"Lopez","year":"2000","journal-title":"Blood"},{"key":"10.3109\/14653249.2012.700766_bib0325","doi-asserted-by":"crossref","first-page":"8444","DOI":"10.1158\/0008-5472.CAN-06-4230","article-title":"The requirement for DNAM-1, NKG2D, and NKp46 in the natural killer cell-mediated killing of myeloma cells","volume":"67","author":"El-Sherbiny","year":"2007","journal-title":"Cancer Res"},{"key":"10.3109\/14653249.2012.700766_bib0330","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1080\/10428190500051893","article-title":"Anti-lymphoma effect of gammadelta T cells","volume":"46","author":"Kunzmann","year":"2005","journal-title":"Leuk Lymphoma"},{"key":"10.3109\/14653249.2012.700766_bib0335","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.blre.2005.10.001","article-title":"Human natural killer cell development and biology","volume":"20","author":"Farag","year":"2006","journal-title":"Blood Rev"},{"key":"10.3109\/14653249.2012.700766_bib0340","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1016\/j.leukres.2007.02.020","article-title":"Differentiation-promoting drugs up-regulate NKG2D ligand expression and enhance the susceptibility of acute myeloid leukemia cells to natural killer cell-mediated lysis","volume":"31","author":"Rohner","year":"2007","journal-title":"Leuk Res"}],"container-title":["Cytotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S146532491271229X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S146532491271229X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T22:16:17Z","timestamp":1761430577000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S146532491271229X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,9]]},"references-count":68,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2012,9]]}},"alternative-id":["S146532491271229X"],"URL":"https:\/\/doi.org\/10.3109\/14653249.2012.700766","relation":{},"ISSN":["1465-3249"],"issn-type":[{"value":"1465-3249","type":"print"}],"subject":[],"published":{"date-parts":[[2012,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Human Vdelta1 gamma-delta T cells exert potent specific cytotoxicity against primary multiple myeloma cells","name":"articletitle","label":"Article Title"},{"value":"Cytotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.3109\/14653249.2012.700766","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 International Society for Cellular Therapy. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}